Literature DB >> 9814547

Changes in NMDAR2 subunit mRNA levels during pentobarbital tolerance/withdrawal in the rat brain: an in situ hybridization study.

C G Jang1, S Oh, I K Ho.   

Abstract

Little is known about the functional modulation of NMDA receptor subunits at the molecular level. Therefore, a series of experiments were conducted to elucidate more fully the role of NMDA receptor subtypes in pentobarbital tolerance and withdrawal. We investigated the influence of centrally administered pentobarbital on the regulation of mRNA levels of the family of NMDA receptor 2 (NR2) subtypes (NR2A, NR2B, and NR2C) by in situ hybridization histochemistry in rat brain. Animals were rendered tolerant by continuous intracerebroventricular (i.c.v.) infusion with pentobarbital (300 microg/10 microl/hr for 6 days) through pre-implanted cannulae connected to osmotic mini-pumps, and dependent, by abrupt withdrawal from pentobarbital. The NR2A subunit mRNA was increased in cortical areas in pentobarbital tolerant and withdrawal rats. In contrast, the NR2B mRNA was decreased in parietal cortex and hippocampus in both tolerance and withdrawal rats. The level of NR2C mRNA was increased in withdrawal rats, while there was no change in tolerant rats. These results indicate that continuous i.c.v. infusion with pentobarbital alters NR2 subunit mRNA expression in the rat brain, suggesting that NR2 subunits may play an important role in the development of tolerance to and withdrawal from pentobarbital.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814547     DOI: 10.1023/a:1020746505854

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  The relative potency of pentobarbital in suppressing the kainic acid- or the N-methyl-D-aspartic acid-induced enhancement of cGMP in cerebellar cells.

Authors:  W W Morgan; J Bermudez; X Y Chang
Journal:  Eur J Pharmacol       Date:  1991-11-12       Impact factor: 4.432

2.  Quinolinate differentiates between forebrain and cerebellar NMDA receptors.

Authors:  D T Monaghan; J A Beaton
Journal:  Eur J Pharmacol       Date:  1991-02-26       Impact factor: 4.432

3.  Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.

Authors:  T Ishii; K Moriyoshi; H Sugihara; K Sakurada; H Kadotani; M Yokoi; C Akazawa; R Shigemoto; N Mizuno; M Masu
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

4.  Role of NMDA receptors in pentobarbital tolerance/dependence.

Authors:  S Oh; K Hoshi; I K Ho
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

5.  Chronic pentobarbital administration alters gamma-aminobutyric acidA receptor alpha 6-subunit mRNA levels and diazepam-insensitive [3H]Ro15-4513 binding.

Authors:  T Ito; T Suzuki; S E Wellman; I K Ho
Journal:  Synapse       Date:  1996-02       Impact factor: 2.562

6.  Chronic ethanol intoxication induces differential effects on GABAA and NMDA receptor function in the rat brain.

Authors:  E Sanna; M Serra; A Cossu; G Colombo; P Follesa; T Cuccheddu; A Concas; G Biggio
Journal:  Alcohol Clin Exp Res       Date:  1993-02       Impact factor: 3.455

7.  Use-dependent pentobarbital block of kainate and quisqualate currents.

Authors:  W Marszalec; T Narahashi
Journal:  Brain Res       Date:  1993-04-09       Impact factor: 3.252

8.  The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.

Authors:  A L Buller; H C Larson; B E Schneider; J A Beaton; R A Morrisett; D T Monaghan
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

9.  Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.

Authors:  M Rabbani; J Wright; A R Butterworth; Q Zhou; H J Little
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

10.  N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.

Authors:  D R Lynch; N J Anegawa; T Verdoorn; D B Pritchett
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

View more
  2 in total

Review 1.  Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia.

Authors:  Anita K Roopun; Mark O Cunningham; Claudia Racca; Kai Alter; Roger D Traub; Miles A Whittington
Journal:  Schizophr Bull       Date:  2008-06-09       Impact factor: 9.306

2.  3-Mercaptopropionic acid-induced repetitive seizures increase GluN2A expression in rat hippocampus: a potential neuroprotective role of cyclopentyladenosine.

Authors:  María Belén Gori; Elena Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-06-08       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.